Additionally, the long-read sequencing market ... instrument sales and higher consumables pull-through. Illumina’s introduction of the MiSeq i100 series demonstrates the company’s commitment ...
Over the past year, the shadow of the Grail deal has hung over Illumina despite its reinvigorated leadership and launch of ...
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, has been named for the sixth ...
The company recently announced the MiSeq i100 series ... and competitive positioning in the global sequencing market. Illumina's emphasis on reducing the total cost of sequencing, rather than ...
SAN DIEGO, March 6, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array ... in 2024 with the launch of the MiSeq i100 Series, which included key ...
The MiSeq desktop sequencer offers low throughput flowcells and long read lengths. It is best for small whole-genome sequencing, targeted gene sequencing, metagenomics, and CRISPR validation. The ...